on the entire genetic codes of two common types of cancer are broken down as scientists begin to unlock a new era in the treatment of fatal diseases.
Scientists at the UK-based Wellcome Trust Sanger Institute cataloged genetic map of the skin and lung cancer and identified specific mutations in DNA, which can lead to dangerous tumors.
Researchers estimate that offer maps of individual patients to treatment vary from previous findings, the type of drugs used to treat cancer.
The genetic map also allows researchers to study cancer cells with DNA damage and produce a stronger medication to combat the errors, the researchers said the study is.
"The knowledge we take in the next few years will have major implications for treatment," Peter Campbell from the Wellcome Trust Sanger Institute said.
"By listing all the genes to develop new cancer drugs that target specific mutated genes, and products which patients will benefit from new treatment options."
Scientists have found that the DNA code of skin cancer, which contains nearly 30,000 errors and lung cancer DNA over 23,000.
"These are the two primary cancers developed for the world that we know the main exhibition," Mike Stratton, Cancer Genome Project of the said.
"In the case of lung cancer is cigarette smoke, and for malignant melanoma is exposure to sunlight.
"The genome sequence, we were able to explore in depth around each tumor detection with high-fidelity fingerprint environmental mutagens on DNA, which occurred years before the tumor has been shown."
The study shows that the error occurs for every 15 cigarettes you smoked.
Scientists in international cancer genome consortium in other countries around the world are completing similar studies - the United Kingdom is looking at breast cancer in the United States and brain cancer, ovary and pancreas, liver, and Japan.
Cancer is the leading cause of death worldwide and maintains more than seven million lives annually according to the World Health Organization.
Scientists at the UK-based Wellcome Trust Sanger Institute cataloged genetic map of the skin and lung cancer and identified specific mutations in DNA, which can lead to dangerous tumors.
Researchers estimate that offer maps of individual patients to treatment vary from previous findings, the type of drugs used to treat cancer.
The genetic map also allows researchers to study cancer cells with DNA damage and produce a stronger medication to combat the errors, the researchers said the study is.
"The knowledge we take in the next few years will have major implications for treatment," Peter Campbell from the Wellcome Trust Sanger Institute said.
"By listing all the genes to develop new cancer drugs that target specific mutated genes, and products which patients will benefit from new treatment options."
Scientists have found that the DNA code of skin cancer, which contains nearly 30,000 errors and lung cancer DNA over 23,000.
"These are the two primary cancers developed for the world that we know the main exhibition," Mike Stratton, Cancer Genome Project of the said.
"In the case of lung cancer is cigarette smoke, and for malignant melanoma is exposure to sunlight.
"The genome sequence, we were able to explore in depth around each tumor detection with high-fidelity fingerprint environmental mutagens on DNA, which occurred years before the tumor has been shown."
The study shows that the error occurs for every 15 cigarettes you smoked.
Scientists in international cancer genome consortium in other countries around the world are completing similar studies - the United Kingdom is looking at breast cancer in the United States and brain cancer, ovary and pancreas, liver, and Japan.
Cancer is the leading cause of death worldwide and maintains more than seven million lives annually according to the World Health Organization.
